Full View

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization …

DL Bhatt, BI Lee, PJ Casterella, M Pulsipher… - Journal of the American …, 2003 - jacc.org
Objectives: This study was designed to assess whether use of enoxaparin during
percutaneous coronary intervention (PCI) increased bleeding compared with unfractionated …
被引用次数：141 相关文章
[PDF] core.ac.uk

[PDF][PDF] Safety of Concomitant Therapy With Eptifibatide and Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention

Journal of the American College of Cardiology, 2003 - core.ac.uk
OBJECTIVES This study was designed to assess whether use of enoxaparin during
percutaneous coronary intervention (PCI) increased bleeding compared with unfractionated …

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization …

DL Bhatt, BI Lee, PJ Casterella… - Journal of the …, 2003 - pubmed.ncbi.nlm.nih.gov
Objectives This study was designed to assess whether use of enoxaparin during
percutaneous coronary intervention (PCI) increased bleeding compared with unfractionated …

[引用][C] Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary …

DL BHATT, BI LEE, GM EATON… - Journal of the …, 2003 - pascal-francis.inist.fr
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing
percutaneous coronary intervention: Results of the coronary revascularization using …

[引用][C] Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary …

B DL - J Am Coll Cardiol, 2003 - cir.nii.ac.jp
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing
percutaneous coronary intervention : Results of the coronary revascularization using integrilin …

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization …

DL Bhatt, BI Lee, PJ Casterella, M Pulsipher… - Journal of the …, 2003 - europepmc.org
Objectives This study was designed to assess whether use of enoxaparin during
percutaneous coronary intervention (PCI) increased bleeding compared with unfractionated …

[引用][C] Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary …

DL Bhatt, BI Lee, PJ Casterella, M Pulsipher… - Journal of the American …, 2003 - elibrary.ru

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary revascularization …

DL Bhatt, BI Lee, PJ Casterella, M Pulsipher… - Journal of the American …, 2003 - infona.pl
This study was designed to assess whether use of enoxaparin during percutaneous
coronary intervention (PCI) increased bleeding compared with unfractionated heparin, in …
[HTML] sciencedirect.com

[HTML][HTML] Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary …

DL Bhatt, BI Lee, PJ Casterella, M Pulsipher… - Journal of the American …, 2003 - Elsevier
OBJECTIVES: This study was designed to assess whether use of enoxaparin during
percutaneous coronary intervention (PCI) increased bleeding compared with unfractionated …

[引用][C] Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary …

DL BHATT, BI LEE, PJ CASTERELLA… - Journal of the American …, 2003 - Elsevier